Literature DB >> 3860885

Increased urine volume in chronic schizophrenic patients.

W B Lawson, C N Karson, L B Bigelow.   

Abstract

Polydipsia and polyuria have a long association with schizophrenia. To assess the prevalence of polydipsia and polyuria in schizophrenia, urine volume was examined in medication-free chronic schizophrenic patients, normal controls, and nonschizophrenic patients. Mean urine volume was significantly higher in the schizophrenic patients (2319 +/- SD 2052 ml/24 hours) than in the other two groups (1054 +/- SD 471 ml/24 hours for nonschizophrenic patients and 1265 +/- SD 613 ml/24 hours for normals). Seven of 35 patients with schizophrenia but 0/7 nonschizophrenics had urine volumes greater than any normal control. Polyuria was associated with a good premorbid history and a positive neuroleptic response. Among polyuric patients, those with hyponatremia may represent a different, distinct subgroup. Neuroleptic treatment was associated with a further, significant increase in urine volume. Hence, polydipsia and polyuria appear to be relatively common in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3860885     DOI: 10.1016/0165-1781(85)90100-3

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Effect of COMT Val108/158Met genotype on risk for polydipsia in chronic patients with schizophrenia.

Authors:  Kenji Yamada; Takahiro Shinkai; Hsin-I Chen; Kensuke Utsunomiya; Jun Nakamura
Journal:  Neuromolecular Med       Date:  2014-01-18       Impact factor: 3.843

Review 2.  Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs.

Authors:  O Spigset; K Hedenmalm
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

3.  Symptomatic hyponatremia associated with psychosis, medications, and smoking.

Authors:  P A Ellinas; F Rosner; J C Jaume
Journal:  J Natl Med Assoc       Date:  1993-02       Impact factor: 1.798

4.  Polydipsia-hyponatraemia syndrome : epidemiology, clinical features and treatment.

Authors:  W V Vieweg; R A Leadbetter
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.